4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001209191-21-029076
Chief Executive Officer acquired 1,592 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hallam Thomas · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-27 | Grant or award : show line 1 in the form | +1,592 | 1,592 | D |
Table II: Derivative
12 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-27 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +4,078 | 4,078 | D |
| 2021-04-27 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +27,189 | 27,189 | D |
| 2021-04-27 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +6,797 | 6,797 | D |
| 2021-04-27 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +477 | 477 | D |
| 2021-04-27 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +2,719 | 2,719 | D |
| 2021-04-27 | Grant or award : show line 7 in the form Stock Option (Right to Buy) | +95,572 | 95,572 | D |
| 2021-04-27 | Grant or award : show line 8 in the form Stock Option (Right to Buy) | +22,730 | 22,730 | D |
| 2021-04-27 | Grant or award : show line 9 in the form Stock Option (Right to Buy) | +8,754 | 8,754 | D |
Loading xslF345X03/doc4.xml…